Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ViroLogic (VLGC) -- Ignore unavailable to you. Want to Upgrade?

To: Don Knowlton who wrote (15)	8/1/2000 2:16:52 PM
From: Ian@SI	Read Replies (1) \| Respond to of 59

Don, During the conference call, if I remember correctly, Bill Young mentioned that marketing efforts had been directed to the AIDS Doctors; going forward, some marketing effort will also be directed toward increasing awareness within the AIDS community that there is a more effective test available. I didn't write down the precise numbers, but I believe that sales progressed in sequential quarters since introduction from $200K to 900K and the most recent Q was $1.9M. There was an interesting announcement this morning re VLGC buying a little over $1M worth of lab test automation equipment from a Cdn supplier. Hopefully this encouraging bit of news can be taken as prima facie evidence that the sales ramp has outpaced their ability to manually meet the demand for testing. :-) Ian.

To: Don Knowlton who wrote (15)	8/29/2000 11:28:41 AM
From: Ian@SI	Read Replies (1) \| Respond to of 59

Did some doodling with the numbers in the San Fran newspaper story... Annual potential revenues are based upon a 240 day year - i.e. 5 day work week less about 20 statutory holidays, preventive maintenance, etc. It appears that substantial growth will be accommodated without sacrificing speed in delivering results back to doctors. Interesting. Ian. ++++++++ Tests per Day 100 300 600 Daily Rev @ $700 each $70,000 $210,000 $420,000 @ $900 each $90,000 $270,000 $540,000 Annual Rev@ $700 each $16,800,000 $50,400,000 $100,800,000 @ $900 each $21,600,000 $64,800,000 $129,600,000